Anti-VEGF treatment strategies for wet AMD

Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

Research output: Contribution to journalReview articlepeer-review

158 Scopus citations


Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

Original languageEnglish (US)
Article number786870
JournalJournal of Ophthalmology
StatePublished - 2012

All Science Journal Classification (ASJC) codes

  • Ophthalmology


Dive into the research topics of 'Anti-VEGF treatment strategies for wet AMD'. Together they form a unique fingerprint.

Cite this